A Food and Drug Administration advisory committee has decided that the threat posed by MDR-TB merits a fast-track approval process for potential new treatments. The clock is ticking, as drug-resistant TB spreads across the globe and scientists search for new drugs to combat this virulent germ. Given that background, the FDA’s Anti-Infective Drugs Advisory Committee [...] |
FDA Panel Says Threat of MDR-TB Warrants Fast-Track for New Drugs
↧
↧
Trending Articles
More Pages to Explore .....